MSGGX | NRGSX | MSGGX / NRGSX | |
Total Expense Ratio | 1.26 | 0.74 | 170% |
Annual Report Gross Expense Ratio | 1.26 | 0.74 | 170% |
Fund Existence | 12 years | 13 years | - |
Gain YTD | -1.340 | -2.693 | 50% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 332M | 8.71B | 4% |
Annual Yield % from dividends | 0.00 | 0.06 | - |
Returns for 1 year | -0.97 | -8.42 | 12% |
Returns for 3 years | 10.51 | 9.23 | 114% |
Returns for 5 years | -20.37 | -0.60 | 3,388% |
Returns for 10 years | 11.81 | 10.18 | 116% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GMCUX | 17.04 | 0.27 | +1.61% |
Goldman Sachs Small/Mid Cap Equity R6 | |||
SAGWX | 6.43 | 0.10 | +1.58% |
Touchstone Small Company A | |||
JFNAX | 74.40 | 0.65 | +0.88% |
Janus Henderson Global Life Sciences A | |||
SGQCX | 43.33 | 0.37 | +0.86% |
DWS International Growth C | |||
ABALX | 39.28 | 0.26 | +0.67% |
American Funds American Balanced A |